Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-06, Stock:JNJ, The news for the past five days is as follows:
2021-09-29: NEWS1: Here's Why Right Now Is a Great Time to Invest in the Stock Market.NEWS2: Here's How a New Investor Started Her Portfolio With Just 10 Top Stocks.NEWS3: Here's Why Investors Shouldn't Count Out Johnson & Johnson as a Coronavirus Vaccine Stock.NEWS4: Here's Why Johnson & Johnson Is a Stock You Can Buy and Hold Forever.NEWS5: UPDATE 1-Slovenia temporarily suspends J&J's Janssen COVID-19 vaccine.NEWS6: UPDATE 1-Swiss buy 150,000 doses of J&J COVID-19 vaccine.NEWS7: Swiss buy 150,000 doses of J&J COVID-19 vaccine.
2021-09-30: NEWS1: Misinformation online 'has significantly handicapped public health efforts': Doctor.NEWS2: UPDATE 1-California judge questions counties' opioid case against drugmakers at trial's end.NEWS3: Why the CDC is urging pregnant women to get vaccinated.NEWS4: California judge questions counties' opioid case against drugmakers at trial's end.NEWS5: ‘There’s been a high rate of Covid-19 among pregnant individuals’: Doctor.NEWS6: 10 High Yield Dividend Champions.NEWS7: J&J (JNJ) Starts Phase III Study on RSV Vaccine in Older Adults.NEWS8: Moderna Is Likely to Get FDA Approval for Smaller Booster,  Report Says.
2021-10-01: NEWS1: Merck’s COVID-19 pill is a 'huge game changer': Doctor.NEWS2: Bayer recalls some lots of Lotrimin, Tinactin antifungal sprays.NEWS3: Vaccinations have mitigated rise of COVID-19 variants: COVID-19 National Task Force Chair.NEWS4: In today's low-rate world, Warren Buffett holds these stocks for the fat yields.NEWS5: Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio.NEWS6: Merck seeks authorization for COVID pill, HHS clarifies HIPAA rights for COVID vaccine.NEWS7: Pregnant women should ‘absolutely get vaccinated as soon as possible,’ doctor urges.NEWS8: Pharma Stock Roundup: MRK to Buy XLRN, ABBV Gets FDA Nod for Migraine Drug & More.NEWS9: UPDATE 2-EU finds J&J COVID shot possibly linked to another rare clotting condition.NEWS10: 2 Mega-Cap Stocks to Buy and Hold For the Next 10 Years.
2021-10-04: NEWS1: U.S. COVID-19 deaths surpass 700K.NEWS2: Merck's new COVID-19 pill 'not a replacement for the vaccine': Doctor.NEWS3: Why Merck's Covid Pill Is Shaking Vaccine Stocks Even As Boosters Launch.NEWS4: Top Analyst Reports for Johnson & Johnson, Alibaba & Netflix.NEWS5: J&J to test experimental RSV vaccine in 23,000 people in Phase 3 clinical study.NEWS6: J&J reportedly seeks FDA approval of booster shot,  William Shatner to blast into space, Oil spill closes CA beaches.NEWS7: JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific Antibody.NEWS8: J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults.NEWS9: Johnson & Johnson Data on RSV Vaccines Raises the Bar in Industrywide Race.NEWS10: Coronavirus tally: Global cases of COVID-19 near 235 million and J&J to seek FDA authorization for booster.NEWS11: UPDATE 2-J&J to seek U.S. FDA authorization of booster shot this week - NYT.NEWS12: Yahoo Finance's interview with Donald Trump.NEWS13: Johnson & Johnson Reportedly Set to Seek FDA OK for Covid Booster.
2021-10-05: NEWS1: 'If you’re not vaccinated, get vaccinated': Doctor.NEWS2: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS3: Xencor (XNCR) Inks Deal With J&J for B-Cell Malignancy Treatment.NEWS4: Positive news on COVID-19 vaccines and treatments in the U.S. weighs against Russia’s latest record one-day death toll.NEWS5: NIH Chief Francis Collins to resign, AstraZeneca seeks COVID treatment authorization.NEWS6: US STOCKS-Wall Street gains as Big Tech bounces from selloff.NEWS7: Johnson & Johnson Asks FDA to Authorize Covid-19 Booster.NEWS8: Xencor Inks Collaboration and License Agreement with Janssen; Shares Rise.NEWS9: Johnson & Johnson Sends Booster Data to FDA. Here’s What Comes Next..NEWS10: US STOCKS-Futures up as Big Tech bounces from selloff; cyclicals rise.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Alibaba, Netflix, Qualcomm and Enbridge.NEWS12: The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout.NEWS13: UPDATE 2-J&J files for authorization of COVID-19 vaccine booster.NEWS14: J&J amends FDA EUA submission for COVID-19 booster with data showing 94% protection against moderate to severe illness.NEWS15: Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine.NEWS16: Here's What to Do When a Stock You Own Sparks Controversy.NEWS17: J&J Gains on Seeking FDA Nod for Covid Booster for Adults.NEWS18: PepsiCo, Facebook And J&J Rise Premarket; Lordstown Motors Slumps.NEWS19: Johnson & Johnson Seeks Formal FDA Approval For COVID Booster Shot.

Answer: Rise